Associated Papers
Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson's Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD Trial.
Peterschmitt MJ et al.
Journal of Parkinson's Disease, 2022
34897099 (PubMed )
Supplement: jpd-12-jpd212714-s001.pdf
The clinical management of Type 2 Gaucher disease.
Weiss K et al.
Molecular Genetics and Metabolism, 2015
Type 2 Gaucher disease: phenotypic variation and genotypic heterogeneity.
Gupta N et al.
Blood Cells, Molecules & Diseases, 2011
The identification of eight novel glucocerebrosidase (GBA) mutations in patients with Gaucher disease.
Orvisky E et al.
Human Mutation, 2002
Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease.
Stone DL et al.
Human Mutation, 2000
Hematologically important mutations: Gaucher disease.
Beutler E et al.
Blood Cells, Molecules & Diseases, 0
Type 2 Gaucher disease occurs in Ashkenazi Jews but is surprisingly rare.
Aviner S et al.
Blood Cells, Molecules & Diseases, 0
Select a paper to view details